BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27191651)

  • 1. Mesenchymal stem cells in combination with erythropoietin repair hyperoxia-induced alveoli dysplasia injury in neonatal mice via inhibition of TGF-β1 signaling.
    Luan Y; Zhang L; Chao S; Liu X; Li K; Wang Y; Zhang Z
    Oncotarget; 2016 Jul; 7(30):47082-47094. PubMed ID: 27191651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
    Wang Y; Lu X; He J; Zhao W
    Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia.
    Rath P; Nardiello C; Surate Solaligue DE; Agius R; Mižíková I; Hühn S; Mayer K; Vadász I; Herold S; Runkel F; Seeger W; Morty RE
    Pediatr Res; 2017 May; 81(5):795-805. PubMed ID: 28141790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxin A
    Chen XQ; Wu SH; Luo YY; Li BJ; Li SJ; Lu HY; Jin R; Sun ZY
    Inflammation; 2017 Dec; 40(6):2094-2108. PubMed ID: 28819748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPO enhances the protective effects of MSCs in experimental hyperoxia-induced neonatal mice by promoting angiogenesis.
    Sun C; Zhang S; Wang J; Jiang W; Xin Q; Chen X; Zhang Z; Luan Y
    Aging (Albany NY); 2019 Apr; 11(8):2477-2487. PubMed ID: 31035257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of BMSCs in combination with erythropoietin in bronchopulmonary dysplasia-induced lung injury.
    Zhang ZH; Pan YY; Jing RS; Luan Y; Zhang L; Sun C; Kong F; Li KL; Wang YB
    Mol Med Rep; 2016 Aug; 14(2):1302-8. PubMed ID: 27279073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hyperoxia and TGF-β1 on epithelial-mesenchymal transition of type II alveolar epithelial cells].
    Liu FJ; Deng C; Guo CB; Fu Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 May; 28(5):474-7. PubMed ID: 22558985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia.
    Zhang Z; Sun C; Wang J; Jiang W; Xin Q; Luan Y
    J Cell Mol Med; 2018 Nov; 22(11):5759-5763. PubMed ID: 30160360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines.
    Chen CL; Chou KJ; Lee PT; Chen YS; Chang TY; Hsu CY; Huang WC; Chung HM; Fang HC
    Exp Cell Res; 2010 Apr; 316(7):1109-18. PubMed ID: 20202468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication.
    Bozyk PD; Bentley JK; Popova AP; Anyanwu AC; Linn MD; Goldsmith AM; Pryhuber GS; Moore BB; Hershenson MB
    PLoS One; 2012; 7(2):e31336. PubMed ID: 22363622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells protect against lung injury in a mouse model of bronchopulmonary dysplasia.
    Luan Y; Ding W; Ju ZY; Zhang ZH; Zhang X; Kong F
    Mol Med Rep; 2015 Mar; 11(3):1945-50. PubMed ID: 25406024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition.
    Vyas-Read S; Wang W; Kato S; Colvocoresses-Dodds J; Fifadara NH; Gauthier TW; Helms MN; Carlton DP; Brown LA
    Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(4):L326-40. PubMed ID: 24375795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-β1 in neonatal rats with hyperoxia-induced bronchopulmonary dysplasia and its relationship with lung development.
    Yan B; Zhong W; He QM; Zhang SY; Yu JK; Pan YL
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats].
    Wang XL; Xue XD
    Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):446-51. PubMed ID: 19951473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runx3 is a key modulator during the epithelial-mesenchymal transition of alveolar type II cells in animal models of BPD.
    Yang H; Fu J; Yao L; Hou A; Xue X
    Int J Mol Med; 2017 Nov; 40(5):1466-1476. PubMed ID: 28949375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.
    Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D
    J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia.
    Tropea KA; Leder E; Aslam M; Lau AN; Raiser DM; Lee JH; Balasubramaniam V; Fredenburgh LE; Alex Mitsialis S; Kourembanas S; Kim CF
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L829-37. PubMed ID: 22328358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia.
    Alejandre-Alcázar MA; Kwapiszewska G; Reiss I; Amarie OV; Marsh LM; Sevilla-Pérez J; Wygrecka M; Eul B; Köbrich S; Hesse M; Schermuly RT; Seeger W; Eickelberg O; Morty RE
    Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L537-49. PubMed ID: 17071723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.